ANNOUNCEMENT

Click here to download pdf brochure for MedCity CONVERGE, to be held July 9-10 in Philadelphia.

Topic: BMRN

Pompe disease therapy wins orphan drug status for BioMarin

Pompe disease therapy wins orphan drug status for BioMarin

August 31, 2010 7:15 pm by | 0 Comments

BioMarin Pharmaceutical Inc. has received orphan drug status for an investigational enzyme replacement therapy to treat Pompe disease that was developed by ZyStor Therapeutics in Milwaukee, Wisconsin. Just two weeks ... Read more